| Financial Year |
March 31 2023 |
| Monetary Funds |
1,352,872,179.09 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
109,041,067.70 |
| Advances to Suppliers |
82,412,685.68 |
| Other Receivables |
3,410,886.71 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
84,402,350.18 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
48,150,790.87 |
| Total Current Assets |
1,720,035,341.55 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
7,848,864.31 |
| Investment Properties |
1,118,965.32 |
| Fixed Assetes |
242,211,002.57 |
| Under-construction Projects |
23,259,140.96 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
389,187.90 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
123,404,796.85 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
286,996,940.37 |
| Other Non-Current Assets |
23,767,843.48 |
| Sub-Total of Non-Current Assets |
710,105,489.57 |
| Total Assets |
2,430,140,831.12 |
| Short-Term Loans |
20,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
741,300,000.00 |
| Accounts Payable |
166,272,583.36 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
68,832,292.56 |
| Taxes Payable |
9,088,904.12 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
114,768,486.75 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
9,316,817.12 |
| Sub-Total of Current Liabilities |
1,221,314,846.82 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
18,518,686.87 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
19,771,792.36 |
| Total Liabilities |
1,241,086,639.18 |
| Paid-In Capital(Or Share Stock) |
1,793,901,141.00 |
| Capital Surplus |
1,083,981,363.21 |
| Surplus Reserve |
82,922,494.20 |
| LESS:Treasury Stock |
50,049,999.00 |
| Undistributed Profits |
-1,487,820,903.82 |
| Minority Stockholder's Interest |
-233,879,903.65 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,422,934,095.59 |
| Owner's Equity（Stockholder's Equity） |
1,189,054,191.94 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,430,140,831.12 |
